Patents by Inventor Jitsutaro KAWAGUCHI

Jitsutaro KAWAGUCHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240060051
    Abstract: Provided is a method for producing naive induced pluripotent stem cells from human somatic cells, comprising the following steps (1) to (3): (1) introducing one or more vectors containing a reprogramming factor into human somatic cells, (2) culturing said somatic cells in the presence of a naive medium, and (3) after step (2), culturing the resulting cells in the presence of the naive medium under the condition in which the amount of the vectors per the somatic cell is reduced to 30% or less of that at the start of step 3.
    Type: Application
    Filed: December 24, 2021
    Publication date: February 22, 2024
    Applicants: Kyoto University, ID PHARMA CO., LTD.
    Inventors: Akira Kunitomi, Tsugumine Shu, Jitsutaro Kawaguchi
  • Publication number: 20200283797
    Abstract: An objective of the present invention is to provide an improved negative-strand RNA viral vector and a use thereof, the negative-strand RNA viral vector exhibiting transient high expression of genes loaded in the vector and enabling the rapid removal of the vector after said expression. It was discovered that by adding a micro-RNA target sequence to the NP, P, or L gene of a negative-strand RNA viral vector, it is possible to control the expression of the vector depending on the micro-RNA expressed by the introduction cell. In particular, when a micro-RNA target sequence was added to the NP or P gene, the expression of the vector decreased depending on the micro-RNA, and the removal of the vector was promoted, while the effect was reversed when a micro-RNA target sequence was added to the L gene. The vector can be applied in cell therapy and regenerative medicine and can be used as a therapeutic vector that targets cancer.
    Type: Application
    Filed: November 4, 2016
    Publication date: September 10, 2020
    Applicant: ID Pharma Co., Ltd.
    Inventors: Koichi SAEKI, Kohji KUSANO, Hiroto HARA, Makoto INOUE, Jitsutaro KAWAGUCHI